Abstract:Rationale: Transplant arteriosclerosis is the major limitation to long-term survival of solid organ transplantation. Although both immune and nonimmune cells have been suggested to contribute to this process, the complex cellular heterogeneity within the grafts, and the underlying mechanisms regulating the disease progression remain largely uncharacterized. Objective: We aimed to delineate the cellular heterogeneity within the allografts, and to explore possible mechanisms underlying this process. Methods and Results: Here, we reported the transcriptional profiling of 11 868 cells in a mouse model of transplant arteriosclerosis by single-cell RNA sequencing. Unbiased clustering analyses identified 21 cell clusters at different stages of diseases, and focused analysis revealed several previously unknown subpopulations enriched in the allografts. Interestingly, we found evidence of the local formation of tertiary lymphoid tissues and suggested a possible local modulation of alloimmune responses within the grafts. Intercellular communication analyses uncovered a potential role of several ligands and receptors, including Ccl21a and Cxcr3 , in regulating lymphatic endothelial cell-induced early chemotaxis and infiltration of immune cells. In vivo mouse experiments confirmed the therapeutic potential of CCL21 and CXCR3 neutralizing antibodies in transplant arteriosclerosis. Combinational use of genetic lineage tracing and single-cell techniques further indicate the infiltration of host-derived c-Kit + stem cells as heterogeneous populations in the allografts. Finally, we compared the immune response between mouse allograft and atherosclerosis models in single-cell RNA-seq analysis. By analyzing susceptibility genes of disease traits, we also identified several cell clusters expressing genes associated with disease risk. Conclusions: Our study provides a transcriptional and cellular landscape of transplant arteriosclerosis, which could be fundamental to understanding the initiation and progression of this disease. CCL21/CXCR3 was also identified as important regulators of immune response and may serve as potential therapeutic targets in disease treatment.

The roles and potential therapeutic implications of CXCL4 and its variant CXCL4L1 in the pathogenesis of chronic liver allograft dysfunction.

Chemokines in Chronic Liver Allograft Dysfunction Pathogenesis and Potential Therapeutic Targets

CXCL4 Contributes to the Pathogenesis of Chronic Liver Allograft Dysfunction

Role of IL-18 in Transplant Biology

Role of the Immune System in Liver Transplantation and Its Implications for Therapeutic Interventions

Inflammasome Activation Involved in Early Inflammation Reaction after Liver Transplantation.

Emerging Importance of Chemokine Receptor CXCR4 and Its Ligand in Liver Disease

Impact of Local Alloimmunity and Recipient Cells in Transplant Arteriosclerosis

Correlation between BAL CXCR3 chemokines and lung allograft histopathologies: A multicenter study

The Role of Toll-Like Receptors 2 and 4 in Acute Allograft Rejection after Liver Transplantation

Intragraft immune cells: accomplices or antagonists of recipient-derived macrophages in allograft fibrosis?

Role of Innate Immunity in Pediatric Post-transplant Idiopathic Liver Fibrosis

Chemokines and Chemokine Receptors Expressed by the Liver and Allo-Reactive CD8+ T Cells in Graft-Versus-host Disease Mouse

Increased Expression of Non-Interleukin-2 T Cell Growth Factors and Their Implications During Liver Allograft Rejection in Rats

Increased expression of non-interleukin-2 T cell growth factors and their implications during liver allograft rejection in rats.

Characterization and Proteomic Analyses of Proinflammatory Cytokines in a Mouse Model of Liver Transplant Rejection

CXCL12/CXCR4: an amazing challenge and opportunity in the fight against fibrosis

New Insights in Mechanisms and Therapeutics for Short- and Long-Term Impacts of Hepatic Ischemia Reperfusion Injury Post Liver Transplantation

Mechanisms of Immune Tolerance in Liver Transplantation-Crosstalk Between Alloreactive T Cells and Liver Cells with Therapeutic Prospects

A proteomic analysis of transplanted liver in a rat model of chronic rejection.

The analysis of hepatic pathological characteristics in different immune conditions after liver transplantation